Latest filing published 02 Aug 2019 for Tetra Bio-Pharma Inc., €14k.
Robert Bechard discloses dealings in Tetra Bio-Pharma Inc. to SEDI. In total, 3 filings cover trades dated from 10 May 2017 to 2 August 2019.
On the market, this insider has only ever bought: 1 purchase, €10k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
Most recently, on 2 August 2019, the filings show a transaction worth €14k in Tetra Bio-Pharma Inc. The most recent open-market purchase was published on 2 August 2017, 3,370 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 6 days. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations